Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. NUTX
NUTX logo

NUTX Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
95.220
Open
92.940
VWAP
91.77
Vol
182.22K
Mkt Cap
633.42M
Low
89.200
Amount
16.72M
EV/EBITDA(TTM)
2.90
Total Shares
6.97M
EV
861.04M
EV/OCF(TTM)
3.47
P/S(TTM)
0.69
Nutex Health Inc. is a healthcare management and operations company. The Company operates in three segments: the Hospital division, the Population Health Management (PHM) division, and the Real Estate division. The Hospital division owns, develops and operates healthcare models, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). This division owns and operates 24 facilities in 11 states. In addition, it has financial and operating relationships with multiple professional entities and real estate entities. The Population Health Management division owns and operates provider networks, such as Independent Physician Associations (IPAs). Through its Management Services Organization (MSO), it provides management, administrative and other support services to its affiliated hospitals and physician groups. The Real Estate division comprises the Real Estate Entities, which owns the land and hospital buildings which are leased to its hospital entities.
Show More

Events Timeline

(ET)
2026-03-06
09:00:00
Oil Prices Surge as Markets Decline Due to Geopolitical Risks
select
2026-03-06
08:10:00
Nutex Health Reports $11.8M Net Income for Q4 2025
select
2026-03-05 (ET)
2026-03-05
19:30:00
Marvell Technology Shares Rise 15% After Earnings
select
2026-03-05
18:50:00
Nutex Health Reports 2025 EPS of $10.48 vs. $9.69 in 2024
select
2026-03-05
18:50:00
Nutex Health Authorizes $25M Stock Repurchase Program
select
2026-03-05
18:50:00
Nutex Health Q4 Revenue $151.7M, Below Expectations
select
2025-12-04 (ET)
2025-12-04
05:40:00
Nutex Health Extends Stock Repurchase Program to March 2026
select
2025-11-26 (ET)
2025-11-26
16:12:33
Nutex Health claims 'Capybara Research appears to be a non-existent entity'
select
2025-11-25 (ET)
2025-11-25
10:43:49
Capybara Research Accuses Nutex Health of Fraudulent Business Practices
select
link
2025-11-19 (ET)
2025-11-19
16:33:18
Nutex Health announces Q3 earnings per share of $7.76 compared to a loss of $1.72 in the previous year.
select

News

Globenewswire
7.0
03-13Globenewswire
Nutex Health Executives Accused of Breach of Fiduciary Duties
  • Investigation Launched: Kuehn Law, PLLC is investigating whether Nutex Health, Inc. executives breached their fiduciary duties to shareholders, with allegations that could lead to severe legal consequences for the company.
  • False Statements Exposed: A federal securities lawsuit claims that Nutex Health failed to disclose fraudulent activities associated with its partnership with HaloMD, resulting in unsustainable revenue and severely impacting financial transparency.
  • Internal Control Deficiencies: The company is accused of overstating its remediation of internal controls over financial reporting, leading to an inability to effectively account for stock-based compensation obligations and increasing the risk of failing to timely file financial reports with the SEC.
  • Shareholder Rights at Risk: Due to these issues, Nutex Health's business prospects were overstated, resulting in materially false and misleading public statements at all relevant times, prompting shareholders to contact legal counsel promptly to protect their rights.
Globenewswire
7.0
03-13Globenewswire
Nutex Health Shares Plunge 24% Amid Investigation for Securities Violations
  • Significant Stock Drop: Nutex Health's shares plummeted over 24% in pre-market trading on March 6, 2026, indicating severe market concerns regarding the company's financial health following its fourth quarter and full-year 2025 results announcement.
  • Reimbursement Claim Issues: The company disclosed that many out-of-network reimbursement claims submitted through the federal Independent Dispute Resolution process were deemed ineligible, resulting in a $55 million cumulative true-up in its financial report, which negatively impacted investor confidence.
  • Legal Investigation Initiated: Prominent law firm Lowey Dannenberg is investigating Nutex Health for potential violations of federal securities laws, and if confirmed, this could lead to significant legal liabilities for the company, further harming shareholder interests.
  • Investor Loss Advisory: Investors who suffered losses exceeding $50,000 in Nutex securities are encouraged to participate in the investigation, which may provide legal support and potential compensation opportunities for affected shareholders.
PRnewswire
7.0
03-12PRnewswire
Pomerantz LLP Investigates Claims for Nutex Health Investors
  • Securities Fraud Investigation: Pomerantz LLP is investigating claims on behalf of Nutex Health, Inc. investors, focusing on whether the company and its executives engaged in securities fraud or other unlawful business practices, which could severely impact investor rights.
  • Declining Financial Performance: Nutex's financial report released on March 5, 2025, revealed a revenue decrease of $105.9 million to $151.7 million for Q4 2025, partly due to a $55 million cumulative adjustment of arbitration claims, highlighting compliance risks faced by the company.
  • Significant Stock Price Drop: Following the earnings report, Nutex's stock price fell by $15.06, or 14.3%, to close at $90.28 per share on March 6, 2026, indicating market concerns regarding the company's financial health.
  • Legal Firm Background: Pomerantz LLP, a prominent securities class action law firm with over 85 years of experience, is dedicated to fighting for the rights of victims of securities fraud and corporate misconduct, suggesting that this investigation may lead to broader legal implications.
Globenewswire
7.0
03-10Globenewswire
Nutex Health Under Investigation as Shares Plunge 24%
  • Significant Stock Drop: Nutex Health's shares plummeted over 24% in pre-market trading on March 6, 2026, indicating severe market concerns regarding its financial health following the release of its fourth quarter and full-year 2025 results.
  • Reimbursement Claim Issues: The company disclosed that many out-of-network reimbursement claims submitted through the federal Independent Dispute Resolution process were deemed ineligible, resulting in a one-time $55 million cumulative true-up for 18,950 arbitration claims, which could undermine investor confidence.
  • Legal Investigation Initiated: Prominent law firm Lowey Dannenberg is investigating Nutex Health for potential violations of federal securities laws, and investors who suffered losses exceeding $50,000 may participate in litigation, further exacerbating negative sentiment in the market.
  • Investor Loss Risk: Given the company's legal scrutiny and financial uncertainties, investors may face heightened risk of losses, particularly if Nutex fails to effectively address its reimbursement claim issues, potentially impacting its future financing capabilities and market performance.
Newsfilter
7.0
03-10Newsfilter
Nutex Health Under Investigation as Shares Plunge 24%
  • Stock Plunge: Nutex Health's shares fell over 24% in pre-market trading on March 6, 2026, indicating severe market concerns regarding its financial health following the release of its Q4 and full-year 2025 results.
  • Reimbursement Claim Issues: The company disclosed that many out-of-network reimbursement claims submitted through the federal Independent Dispute Resolution process were deemed ineligible, leading to diminished investor confidence in future revenues and potential market share loss.
  • Arbitration Claim Adjustment: Nutex reported a one-time $55 million cumulative adjustment involving 18,950 arbitration claims that were ruled ineligible, significantly impacting the company's finances and potentially triggering further legal actions.
  • Legal Investigation Initiated: Lowey Dannenberg P.C. is investigating whether Nutex Health violated federal securities laws, and investors who suffered losses exceeding $50,000 may participate in this investigation, further exacerbating market uncertainty.
NASDAQ.COM
4.5
03-07NASDAQ.COM
US Stocks Plunge Amid Rising Energy Prices and Labor Market Concerns
  • Market Weakness: The S&P 500 index fell by 1.33%, and the Dow Jones Industrial Average hit a 3.5-month low, reflecting investor concerns over the Middle East conflict potentially driving energy prices higher and sparking inflation risks, which dampens market confidence.
  • Disappointing Employment Data: The US nonfarm payrolls unexpectedly dropped by 92,000 in February, with the unemployment rate rising to 4.4%, indicating a weakening labor market that raises doubts about economic health and may lead the Fed to adopt a more cautious approach in future policy adjustments.
  • Surge in Energy Prices: WTI crude oil prices surged over 12% to a 2.5-year high as the ongoing Middle East conflict exacerbates supply concerns, which is expected to push global oil prices even higher, impacting profitability across related sectors.
  • Corporate Earnings Resilience: Despite the overall market decline, 74% of S&P 500 companies reported earnings that exceeded expectations, with Q4 earnings growth projected at 8.4%, demonstrating a degree of resilience among businesses that may support future market recovery.
Wall Street analysts forecast NUTX stock price to rise
2 Analyst Rating
Wall Street analysts forecast NUTX stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
230.00
Averages
265.00
High
300.00
Current: 0.000
sliders
Low
230.00
Averages
265.00
High
300.00
Maxim
Maxim
Buy
downgrade
$225 -> $205
AI Analysis
2025-08-26
Reason
Maxim
Maxim
Price Target
$225 -> $205
AI Analysis
2025-08-26
downgrade
Buy
Reason
Maxim lowered the firm's price target on Nutex Health to $205 from $225 and keeps a Buy rating on the shares. On August 14th, the company filed an NT 10-Q notification of inability to timely file its 10-Q for the three months ended 6/30/25, due to the incorrect accounting classification of certain non-cash obligations, the analyst tells investors in a research note. The firm views the accounting restatements, arbitration dynamics, and lawsuits against Nutex's primary arbitration vendor, HaloMD, as potential headwinds to the stock price, Maxim added.
Maxim
Maxim
Buy
maintain
$100 -> $225
2025-05-20
Reason
Maxim
Maxim
Price Target
$100 -> $225
2025-05-20
maintain
Buy
Reason

Valuation Metrics

The current forward P/E ratio for Nutex Health Inc (NUTX.O) is 8.47, compared to its 5-year average forward P/E of -23.37. For a more detailed relative valuation and DCF analysis to assess Nutex Health Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-23.37
Current PE
8.47
Overvalued PE
72.86
Undervalued PE
-119.60

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
60.18
Current EV/EBITDA
3.97
Overvalued EV/EBITDA
168.96
Undervalued EV/EBITDA
-48.60

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
3.06
Current PS
1.02
Overvalued PS
10.25
Undervalued PS
-4.13

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

what are some good small cap stocks to buy
Intellectia · 27 candidates
Market Cap: 300.00M - 2.00BBeta: ModerateRiskWeekly Average Turnover: >= 1,000,000Pe Ttm: <= 16Annual Revenue Yoy Growth: >= 25.0%
Ticker
Name
Market Cap$
top bottom
CMRE logo
CMRE
Costamare Inc
1.91B
AGIO logo
AGIO
Agios Pharmaceuticals Inc
1.58B
AESI logo
AESI
Atlas Energy Solutions Inc
1.44B
TWO logo
TWO
Two Harbors Investment Corp
1.40B
QURE logo
QURE
Uniqure NV
1.35B
IMTX logo
IMTX
Immatics NV
1.34B

Whales Holding NUTX

D
Divisadero Street Capital Management, LP
Holding
NUTX
-10.27%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Nutex Health Inc (NUTX) stock price today?

The current price of NUTX is 90.9 USD — it has decreased -3.1

What is Nutex Health Inc (NUTX)'s business?

Nutex Health Inc. is a healthcare management and operations company. The Company operates in three segments: the Hospital division, the Population Health Management (PHM) division, and the Real Estate division. The Hospital division owns, develops and operates healthcare models, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). This division owns and operates 24 facilities in 11 states. In addition, it has financial and operating relationships with multiple professional entities and real estate entities. The Population Health Management division owns and operates provider networks, such as Independent Physician Associations (IPAs). Through its Management Services Organization (MSO), it provides management, administrative and other support services to its affiliated hospitals and physician groups. The Real Estate division comprises the Real Estate Entities, which owns the land and hospital buildings which are leased to its hospital entities.

What is the price predicton of NUTX Stock?

Wall Street analysts forecast NUTX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NUTX is265.00 USD with a low forecast of 230.00 USD and a high forecast of 300.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Nutex Health Inc (NUTX)'s revenue for the last quarter?

Nutex Health Inc revenue for the last quarter amounts to 151.68M USD, decreased -41.12

What is Nutex Health Inc (NUTX)'s earnings per share (EPS) for the last quarter?

Nutex Health Inc. EPS for the last quarter amounts to 1.56 USD, decreased -82.47

How many employees does Nutex Health Inc (NUTX). have?

Nutex Health Inc (NUTX) has 944 emplpoyees as of March 31 2026.

What is Nutex Health Inc (NUTX) market cap?

Today NUTX has the market capitalization of 633.42M USD.